Antibiotic Resistance Lab Network Carbapenemase Genes, plus
C. difficile Infections in Hospitalized Patients
Data Now Available

In the Antibiotic Resistance & Patient Safety Portal (AR&PSP)

CDC’s AR Lab Network is an effort to rapidly identify antibiotic resistance genes and germs that could cause hard-to-treat or potentially untreatable infections.

For the first time, CDC’s AR Lab Network is reporting data about carbapenemase genes it has detected through nationwide testing. Data show that carbapenemase genes, which can make life-saving antibiotics ineffective, were found in only a minority of U.S. isolates. The Containment Strategy must continue to keep these unusual threats from spreading like wildfire. The new data are featured in CDC’s Antibiotic Resistance & Patient Safety Portal (AR&PSP).

CDC’s AR Lab Network supports nationwide lab capacity to rapidly detect antibiotic resistance and inform local responses to prevent spread and protect people. The network provides local experts with the data needed to combat AR in healthcare, food, and the community. The AR&PSP only displays the healthcare-associated infection data collected by the AR Lab Network.

AR&PSP data displays a national snapshot of carbapenemase genes detected in 2017 and 2018 in 3 priority organisms (Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii) and carbapenemase gene screens (also known as colonization screening). It also includes profiles for the 3 priority organisms and colonization screens, including details of numbers and percentages of isolates, genes detected, and geographical distributions.